Global Infusion Pharmacy Management Market Growth (Status and Outlook) 2023-2029

Global Infusion Pharmacy Management Market Growth (Status and Outlook) 2023-2029

Infusion therapy is prescribed to patient only when patient condition is severe or oral medication are less effective. Infusion Pharmacy includes infusion of antibiotic, antifungal, antiviral, pain management and nutritional drug through needle or catheter. Diseases such as cancer, diabetes, gastrointestinal disorder and pain related disorders are generally treated with infusion medication system. Infusion pharmacy can also be administered in home by providing doorstep services. Home infusion pharmacy management is more costly than hospital infusion pharmacy management because it requires more skilled nursing facilities. This report studies the Infusion Pharmacy Management market.
LPI (LP Information)' newest research report, the “Infusion Pharmacy Management Industry Forecast” looks at past sales and reviews total world Infusion Pharmacy Management sales in 2022, providing a comprehensive analysis by region and market sector of projected Infusion Pharmacy Management sales for 2023 through 2029. With Infusion Pharmacy Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infusion Pharmacy Management industry.
This Insight Report provides a comprehensive analysis of the global Infusion Pharmacy Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infusion Pharmacy Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infusion Pharmacy Management market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infusion Pharmacy Management and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infusion Pharmacy Management.
The global Infusion Pharmacy Management market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
In United States market, Infusion Pharmacy Management key players include BioScrip, BD, Cigna, Option Care, CVS Health, etc. The top five manufacturers hold a share about 70%. South is the largest market, with a share about 35%, followed by Midwest, with a share about 20 percent. In terms of product, Antimicrobial is the largest segment, with a share about 20%. And in terms of application, the largest application is Home Care, followed by Hospital & Clinic, Ambulatory Surgical Centers, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Infusion Pharmacy Management market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Antibiotics
Antimicrobial
Pain Management
Enteral Nutrition
Others
Segmentation by application
Hospital & Clinic
Ambulatory Surgical Centers
Home Care
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BioScrip
BD
Cigna
Option Care
CVS Health
McKesson
Mediware
OptumRx
Healix
CareCentrix
MedicoRx
Ivenix
ARJ Infusion Services
Brightree
Accredo Health
MHA
ContinuumRx

Please note: The report will take approximately 2 business days to prepare and deliver.